Stories

People lorem ipsum dolor sit amet

Sed consequat, dui consequat congue dignissim,

Sed et bibendum odio. Sed molestie tempus ex, in fringilla elit auctor ut. Donec hendrerit eros

2 min. read or listen
Published on 23/09/2022
Read More

Lorem ipsum dolor sit amet, consectetur adipiscing

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean iaculis et urna sit amet egestas.

2 min. read or listen
Published on 23/09/2022
Read More

Etiam sodales elementum arcu eu porttitor

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris nec tortor volutpat, euismod orci

2 min. read or listen
Published on 20/09/2022
Read More

Sed a enim aliquet odio facilisis pretium

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Phasellus sed elementum nibh. Quisque

2 min. read or listen
Published on 19/07/2022
Read More

You might also enjoy our news

AlmirallShare 7th call is out now!

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Innovative therapies for vitiligo

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Understanding hidradenitis suppurativa

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa

Subscribe to our latest news